Quick Answer
Oncotelic Therapeutics, Inc. reported Shares Outstanding of 407.29 million shares for fiscal year 2024.
Oncotelic Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 407.29M | +2.0% |
| 2023 | 399.18M | +1.9% |
| 2022 | 391.85M | +4.4% |
| 2021 | 375.29M | +314.2% |
| 2020 | 90.60M | +7.8% |
| 2019 | 84.07M | +1128.4% |
| 2018 | 6.84M | -74.2% |
| 2017 | 26.55M | +0.0% |
| 2016 | 26.55M | +0.0% |
| 2015 | 26.55M | +28.2% |
| 2014 | 20.70M | +270.7% |
| 2013 | 5.59M | +219.9% |
| 2012 | 1.75M | +38.0% |
| 2011 | 1.26M | -77.0% |
| 2010 | 5.50M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 439.45M | +7.9% | +7.6% |
| June 30, 2025 | 408.29M | +0.2% | +0.0% |
| March 31, 2025 | 408.29M | +2.2% | +0.2% |
| December 31, 2024 | 407.29M | +2.0% | +0.0% |
| September 30, 2024 | 407.29M | +2.3% | +0.0% |
| June 30, 2024 | 407.29M | +2.5% | +1.9% |
| March 31, 2024 | 399.68M | +1.7% | +0.1% |
| December 31, 2023 | 399.18M | +1.9% | +0.3% |
- Oncotelic Therapeutics, Inc. showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2024 period, Oncotelic Therapeutics, Inc.’s shares outstanding has grown by 7303.9% (from 5.50 million shares to 407.29 million shares).
- The most recent figure is from Oncotelic Therapeutics, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: